Literature DB >> 35411425

Spanlastics a Novel Nanovesicular Carrier: Its Potential Application and Emerging Trends in Therapeutic Delivery.

Mohd Danish Ansari1, Zoya Saifi1, Jayamanti Pandit1, Iram Khan1, Pavitra Solanki1, Yasmin Sultana2, Mohd Aqil1.   

Abstract

Nanotechnology-based drug delivery system has played a very crucial role in overpowering the tasks allied with the conventional dosage form. Spanlastics, an elastic nanovesicle with an ability to carry wide range of drug molecules, make it a potential drug delivery carrier. Spanlastics have extended rising curiosity for diverse sort of route of administration. They can squeeze themselves through the skin pore due to elastic and deformable nature which makes them favorable for transdermal delivery. Spanlastics consist of non-ionic surfactant or blend of surfactants. Many researchers proved that spanlastics have been significantly augment therapeutic efficacy, enhanced drug bioavailability, and reduced drug toxicity. This review summarizes various vesicular systems, composition and structure of spanlastics, advantages of spanlastics over other drug delivery systems, and mechanism of drug penetration through skin. It also gives a brief on different types of drug encapsulated in spanlastics vesicles for the treatment of various diseases.
© 2022. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  deformable and elastic vesicle; drug delivery; edge activator; nanotechnology; spanlastic

Mesh:

Substances:

Year:  2022        PMID: 35411425     DOI: 10.1208/s12249-022-02217-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  14 in total

1.  Spanlastics--a novel nanovesicular carrier system for ocular delivery.

Authors:  Shilpa Kakkar; Indu Pal Kaur
Journal:  Int J Pharm       Date:  2011-04-21       Impact factor: 5.875

2.  Enhanced non invasive trans-tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication, in-vitro characterization, and comparative ex-vivo permeation studies.

Authors:  Abdulaziz Mohsen Al-Mahallawi; Omneya Mohammed Khowessah; Raguia Ali Shoukri
Journal:  Int J Pharm       Date:  2017-03-07       Impact factor: 5.875

Review 3.  Combined use of nanocarriers and physical methods for percutaneous penetration enhancement.

Authors:  Nina Dragicevic; Howard Maibach
Journal:  Adv Drug Deliv Rev       Date:  2018-02-06       Impact factor: 15.470

4.  Novel antipsoriatic fluidized spanlastic nanovesicles: In vitro physicochemical characterization, ex vivo cutaneous retention and exploratory clinical therapeutic efficacy.

Authors:  Enas Elmowafy; Riham I El-Gogary; Maha H Ragai; Maha Nasr
Journal:  Int J Pharm       Date:  2019-07-23       Impact factor: 5.875

5.  Nanostructured lipid carrier to overcome stratum corneum barrier for the delivery of agomelatine in rat brain; formula optimization, characterization and brain distribution study.

Authors:  Shakeeb Ahmed; Syed Mahmood; Mohd Danish Ansari; Azka Gull; Nitin Sharma; Yasmin Sultana
Journal:  Int J Pharm       Date:  2021-08-12       Impact factor: 5.875

6.  Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.

Authors:  Noha Ibrahim Elsherif; Rehab Nabil Shamma; Ghada Abdelbary
Journal:  AAPS PharmSciTech       Date:  2016-05-02       Impact factor: 3.246

7.  Poloxamer-407 thickened lipid colloidal system of agomelatine for brain targeting: Characterization, brain pharmacokinetic study and behavioral study on Wistar rats.

Authors:  Shakeeb Ahmed; Azka Gull; Mohd Aqil; Mohd Danish Ansari; Yasmin Sultana
Journal:  Colloids Surf B Biointerfaces       Date:  2019-05-08       Impact factor: 5.268

8.  Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund's adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway.

Authors:  Shahira F El Menshawe; Mohamed M Nafady; Heba M Aboud; Rasha M Kharshoum; Asmaa Mohammed M Hussein Elkelawy; Doaa S Hamad
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

9.  Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate.

Authors:  Abdul Ahad; Abdulmohsen A Al-Saleh; Abdullah M Al-Mohizea; Fahad I Al-Jenoobi; Mohammad Raish; Alaa Eldeen B Yassin; Mohd Aftab Alam
Journal:  Saudi Pharm J       Date:  2017-02-02       Impact factor: 4.330

10.  Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies.

Authors:  Abdurrahman M Fahmy; Doaa Ahmed El-Setouhy; Ahmed B Ibrahim; Basant A Habib; Saadia A Tayel; Noha A Bayoumi
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

View more
  1 in total

1.  Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells.

Authors:  Aml I Mekkawy; Nermin E Eleraky; Ghareb M Soliman; Mohamed G Elnaggar; Marwa G Elnaggar
Journal:  Pharmaceutics       Date:  2022-08-18       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.